The future: Critical knowledge about anti-itch therapy

Dermatologic Therapy

Volumn 18, Issue 4, 2005, Pages 363-365

  Guarneri, Claudio ^a   Terranova, Margherita ^b   Terranova, Giuseppe ^c   Guarneri, Fabrizio ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Itch; Neuromediators; Pathogenesis; Protease activated receptors; Therapy

Indexed keywords

ACETYLCHOLINE; ANANDAMIDE; ANTIPRURITIC AGENT; CALAMINE; CAPSAICIN; CHYMASE; DEXANABINOL; DOXEPIN; GLUCOCORTICOID; GLYCINE; ICOSANOID; INTERFERON; INTERLEUKIN 2; LOCAL ANESTHETIC AGENT; NEDOCROMIL SODIUM; NEUROTROPHIN 4; NORADRENALIN; OLIGOSACCHARIDE; OPIATE ANTAGONIST; PAPAIN; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; SEDATIVE AGENT; SEROTONIN; STRONTIUM; SUBSTANCE P; TANDOSPIRONE; TRYPSIN; UNINDEXED DRUG; VANILLOID RECEPTOR 1;

ANXIETY; ATOPIC DERMATITIS; DEPRESSION; DRUG FATALITY; DRUG MECHANISM; DRUG TOLERANCE; ERYTHEMA; EVIDENCE BASED MEDICINE; HUMAN; MAST CELL; NERVOUS SYSTEM; NONHUMAN; PAIN; PRURITUS; REVIEW; URTICARIA;

ANTIPRURITICS; CAPSAICIN; DRUG THERAPY, COMBINATION; HUMANS; NARCOTIC ANTAGONISTS; NEURAL PATHWAYS; PROTEASE INHIBITORS; PRURITUS;

EID: 29144464127     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2005.00030.x     Document Type: Review

References (15)

1. Birò T, Ko MC, Bromm B, et al. How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol 2005: 14: 225-240.
2. Ebata T, Iwasaki S, Kamide R, Niimura M. Use of a wrist activity monitor for the measurement of nocturnal scratching in patients with atopic dermatitis. Br J Dermatol 2001: 144: 305-309.
3. Tausk FA, Nousari H. Stress and the skin. Arch Dermatol 2001: 137: 78-82.
4. Schmelz M, Schmidt R, Bickel A, et al. Specific C receptors for itch in human skin. J Neurosci 1997: 17: 8003-8008.
5. Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 2001: 4: 72-77.
6. Bigliardi-Qi M, Lipp B, Sumanovski LT, et al. Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 2005: 210: 91-99.
7. Treede RD, Apkarian AV, Bromm B, et al. Cortical representation of pain: functional characterization of nociceptive areas near the lateral sulcus. Pain 2000: 87: 113-119.
8. Urashima R, Mihara M. Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. Virchows Arch 1998: 432: 363-370.
9. Grewe M, Vogelsang K, Ruzicka T, et al. Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis. J Invest Dermatol 2000: 114: 1108-1112.
10. Toyoda M, Nakamura M, Makino T, et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002: 147: 71-79.
11. Nilsson HJ, Schouenborg J. Differential inhibitory effect on human nociceptive skin senses induced by local stimulation of thin cutaneous fibers. Pain 1999: 80: 103-112.
12. Szallasi A, Di Marzo V. New perspectives on enigmatic vanilloid receptors. Trends Neurosci 2000: 23: 491-497.
13. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004: 84: 579-621.
14. Steinhoff M, Vergnolle N, Young SH, et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000: 6: 151-158.
15. Storck J, Kusters B, Vahland M, et al. Trypsin induced von Willebrand factor release from human endothelial cells in mediated by PAR-2 activation. Thromb Res 1996: 84: 463-473.